98%
921
2 minutes
20
Background: Data extraction and integration methods are becoming essential to effectively access and take advantage of the huge amounts of heterogeneous genomics and clinical data increasingly available. In this work, we focus on The Cancer Genome Atlas, a comprehensive archive of tumoral data containing the results of high-throughout experiments, mainly Next Generation Sequencing, for more than 30 cancer types.
Results: We propose TCGA2BED a software tool to search and retrieve TCGA data, and convert them in the structured BED format for their seamless use and integration. Additionally, it supports the conversion in CSV, GTF, JSON, and XML standard formats. Furthermore, TCGA2BED extends TCGA data with information extracted from other genomic databases (i.e., NCBI Entrez Gene, HGNC, UCSC, and miRBase). We also provide and maintain an automatically updated data repository with publicly available Copy Number Variation, DNA-methylation, DNA-seq, miRNA-seq, and RNA-seq (V1,V2) experimental data of TCGA converted into the BED format, and their associated clinical and biospecimen meta data in attribute-value text format.
Conclusions: The availability of the valuable TCGA data in BED format reduces the time spent in taking advantage of them: it is possible to efficiently and effectively deal with huge amounts of cancer genomic data integratively, and to search, retrieve and extend them with additional information. The BED format facilitates the investigators allowing several knowledge discovery analyses on all tumor types in TCGA with the final aim of understanding pathological mechanisms and aiding cancer treatments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210259 | PMC |
http://dx.doi.org/10.1186/s12859-016-1419-5 | DOI Listing |
Int J Biol Macromol
September 2025
Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli District, Taoyuan City 320315, Taiwan. Electronic address:
A systematic purification process for His-tagged enhanced green fluorescent protein (His-EGFP) from recombinant E. coli was developed using immobilized metal affinity chromatography (IMAC) in a packed bed format. Large-scale fermentation was conducted in a 5 L bioreactor, followed by cell harvesting and sonication-based disruption at 20 kHz and 4 °C.
View Article and Find Full Text PDFHosp Pediatr
August 2025
Center for Simulation and Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Objective: We used simulation-based clinical systems testing (SbCST) to identify and mitigate latent safety threats (LSTs) before opening a large critical care building (CCB) at a pediatric institution.
Methods: We completed an SbCST project to identify LSTs before opening a 7-floor, 319-bed CCB at a pediatric institution. The extensive preparation process included warehouse planning sessions and a formal intake process.
Front Health Serv Manage
August 2025
Doug Niedzwiecki, FACHE,is senior vice president UCI Health Community Network at UCI Health in Orange, California.
University of California (UCI) Health acquired an integrated healthcare delivery system from Tenet Healthcare in March 2024. The acquisition, which included four hospitals and added 858 beds to the system, was a pivotal move toward pursuing the organization's commitment to the long-term health needs of the region and progressing UCI Health's strategic priorities to improve health, increase sustainability, and transform healthcare. Following the acquisition, UCI Health embarked on a journey to integrate the system.
View Article and Find Full Text PDFJ Proteome Res
September 2025
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States.
The effective separation of complex peptide mixtures is a cornerstone of mass spectrometry-based proteomics analysis as it enhances the accuracy and depth of proteomic analyses. Here, we compare data sets collected of whole-cell tryptic peptides, which were fractionated by either conventional flame-pulled, C18 packed-bed microcapillary columns or a microfabricated pillar array column (μPAC). Sixteen samples that included four different yeast strains (Δ, Δ, Δ, and wildtype) were analyzed in quadruplicate using data-independent acquisition.
View Article and Find Full Text PDFFront Bioeng Biotechnol
August 2025
UCL Institute for Liver and Digestive Health, UCL Medical School, London, United Kingdom.
Introduction: alternative therapies to complement liver transplantation and treat patients with liver failure are not available. In this study, a clinical scale single-use biocartridge was developed for use as part of a novel Bioartificial Liver device (HepatiCan™), utilising conditioned human-derived alginate encapsulated liver spheroids (AELS), within a fluidised bed.
Methods: to develop the optimal biocartridge, two designs (B2 and B3) were created and modelled to best replicate the performance of our preexisting reusable cartridge (B1).